New study on M?ori, Pasifika, elderly response to Covid-19 vaccine - a podcast by RNZ

A clinical study getting underway in Rotorua and Christchurch will provide valuable information on how our the population responds to the Pfizer-BioNTech Covid-19 vaccine.
The study aims to enrol at least 300 adult participants with a focus on Maori, Pasifika, adults 65 years old and older, and those with co-morbidities associated with increased risk of Covid-19.
The study will assess immune responses for up to 12 months after the last vaccine dose.
Sela Jane Hopgood delves into what the study entails.

Further episodes of Checkpoint

Further podcasts by RNZ

Website of RNZ